- Home
- PTGX vs HRMY Comparison
PTGX vs HRMY Comparison
Compare PTGX & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- HRMY
- Stock Information
- Founded
- PTGX 2006
- HRMY 2017
- Country
- PTGX United States
- HRMY United States
- Employees
- PTGX N/A
- HRMY N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- PTGX Health Care
- HRMY Health Care
- Exchange
- PTGX Nasdaq
- HRMY Nasdaq
- Market Cap
- PTGX 2.4B
- HRMY N/A
- IPO Year
- PTGX 2016
- HRMY 2020
- Fundamental
- Price
- PTGX $47.65
- HRMY $32.97
- Analyst Decision
- PTGX Strong Buy
- HRMY Strong Buy
- Analyst Count
- PTGX 8
- HRMY 8
- Target Price
- PTGX $66.50
- HRMY $54.00
- AVG Volume (30 Days)
- PTGX 1.7M
- HRMY 692.3K
- Earning Date
- PTGX 05-06-2025
- HRMY 04-29-2025
- Dividend Yield
- PTGX N/A
- HRMY N/A
- EPS Growth
- PTGX N/A
- HRMY 17.84
- EPS
- PTGX 4.23
- HRMY 2.51
- Revenue
- PTGX $434,433,000.00
- HRMY $714,734,000.00
- Revenue This Year
- PTGX N/A
- HRMY $20.92
- Revenue Next Year
- PTGX $8.12
- HRMY $18.83
- P/E Ratio
- PTGX $11.56
- HRMY $13.22
- Revenue Growth
- PTGX 624.05
- HRMY 22.80
- 52 Week Low
- PTGX $24.22
- HRMY $28.14
- 52 Week High
- PTGX $60.60
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- PTGX 53.01
- HRMY 42.30
- Support Level
- PTGX $51.06
- HRMY $32.85
- Resistance Level
- PTGX $53.70
- HRMY $33.77
- Average True Range (ATR)
- PTGX 2.58
- HRMY 1.19
- MACD
- PTGX -0.81
- HRMY 0.01
- Stochastic Oscillator
- PTGX 0.72
- HRMY 23.06
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.